摘要
目的:探讨超脉冲等离子(PKSP)切除治疗高危重度前列腺增生(BPH)的疗效及安全性。方法:应用超脉冲等离子切除治疗高危重度BPH患者48例。结果:本组均安全耐受手术。手术时间40～120 min,平均67 min。灌注液量9 000～45 000 ml,平均9 850 ml。手术前后血清钠、Hb、HCT应用统计学处理,差异无统计学意义(P>0.05)。术后3～5 d拔除导尿管,患者均顺利排尿。术后1个月时,IPSS评分下降至6～15分,平均6.8分;QOL平均降至2.0分;MFR上升到14～26 ml/s,平均上升17.6 ml/s,手术前后比较,差异均有统计学意义(均P<0.01)。结论:PKSP切除治疗高危重度BPH的疗效确切,安全可靠。
Objective： To evaluate the safety and effectiveness of the plasmakinetic superpulse transurethral resecti of prostate in high risk patients with large volume benign prostate hyperplasia.Methods： Plasmakinetic superpulse transurethral resecti for severe benign prostatic hyperplasia patients in 48 cases.Results： All patients could endure the operation.The operative time was 40-120 min（average 67 min）,the perfusate volume was 9 000-45 000 ml（average 9 850 ml）.There was no significant difference on the Na,Hb,HCT in serum before and after treatment（P0.05）.The catheter was removed 3-5 days after operation and the patients were well.After one months,IPSS scores decreased to 6-15 scores（average 6.8 scores）,quality of life score（QOL） decreased to 2.0 scores,MFR increased to 14-26 ml/s（average 17.6 ml/s）,there were significant differences before and after operation（all P0.01）.Conclusion： Plasmakinetic superpulse transurethral resection is a safe,less complications and effective,wide indication method.
出处
《中国医药导报》
CAS
2010年第36期126-127,共2页
China Medical Herald
基金
河南省郑州市创新型科技人才队伍建设工程基金项目:郑州市医学科技攻关项目资助课题(项目编号:200813-18)
关键词
前列腺增生
等离子电切
经尿道前列腺电切术
Benign prostatic hyperplasia
Plasmakentic
Transurethral resection of prostate
